The magnitude of fold change of the TGFB1 protein was observed to be higher in the plasma samples of glioma patients relative to healthy controls; this protein was shown to be a target of chemokine receptor 7 (CCR7) by Zheng et al. [31]. The gene discussed is TGFB1; the disease is central nervous system cancer.